{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:25:09Z","timestamp":1762925109028,"version":"3.45.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) often leads to renal anemia, a complication traditionally treated with erythropoiesis-stimulating agents (ESAs) and iron supplementation. However, these treatments may increase cardiovascular risks. Procyanidin, a compound found in black goji berries and mulberries, has known kidney-protective properties. This study aimed to explore the synergistic effects of procyanidin and roxadustat in alleviating renal anemia in CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mouse model of CKD was induced by administering adenine, followed by treatment with procyanidin (250 mg\/kg\/day), roxadustat (5 mg\/kg\/day), or both. The effects on erythropoiesis, kidney function, iron metabolism, and inflammation were assessed through hematological analyses, histopathology, and gene expression profiling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Procyanidin alone improved erythropoiesis, kidney function, and reduced renal injury. Roxadustat enhanced erythropoiesis and iron metabolism but showed no significant effect on kidney function. The combination of both compounds resulted in superior improvements in hematological parameters, reduced kidney injury, fibrosis, and inflammation, and enhanced iron mobilization and absorption. Notably, procyanidin mitigated the thrombopoiesis induced by roxadustat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The combination of procyanidin and roxadustat provides a promising therapeutic approach for renal anemia by improving erythropoiesis, kidney function, and iron metabolism while reducing adverse effects, such as thrombosis. These findings suggest that procyanidin may enhance the safety and efficacy of roxadustat in CKD-related renal anemia. Further studies are needed to optimize treatment regimens for clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1678846","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:20:05Z","timestamp":1762924805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Procyanidin displayed a synergistic effect with roxadustat on renal anemia in mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Mingyang","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"B1","first-page":"28","article-title":"Grape seed extract for reduction of renal disturbances following reperfusion in rats","volume":"7","author":"Ashtiyani","year":"2013","journal-title":"Iran. J. Kidney Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/biomedicines12061191","article-title":"Anemia of chronic kidney Disease-A narrative review of its pathophysiology, diagnosis, and management","volume":"12","author":"Badura","year":"2024","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.24272\/j.issn.2095-8137.2017.055","article-title":"Kidney disease models: tools to identify mechanisms and potential therapeutic targets","volume":"39","author":"Bao","year":"2018","journal-title":"Zoological Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1007\/s12325-021-01903-7","article-title":"Efficacy and cardiovascular safety of roxadustat in dialysis-dependent chronic kidney disease: pooled analysis of four phase 3 studies","volume":"38","author":"Barratt","year":"2021","journal-title":"Adv. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/febs.14606","article-title":"Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases","volume":"286","author":"Bissinger","year":"2019","journal-title":"FEBS J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"Cd010590","DOI":"10.1002\/14651858.CD010590.pub3","article-title":"Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis","volume":"2","author":"Chung","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/toxins16110495","article-title":"Gut dysbiosis and its role in the anemia of chronic kidney disease","volume":"16","author":"Coll","year":"2024","journal-title":"Toxins (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: first global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0014-827x(01)01063-1","article-title":"Oxidants and antioxidants in long-term haemodialysis patients","volume":"56","author":"Drai","year":"2001","journal-title":"Farmaco"},{"key":"B15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1681\/ASN.2020081150","article-title":"Roxadustat for treating anemia in patients with CKD not on dialysis: results from a randomized phase 3 study","volume":"32","author":"Fishbane","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s11255-011-9947-4","article-title":"Transferrin changes in haemodialysed patients","volume":"44","author":"Formanowicz","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.kisu.2020.12.002","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease","volume":"11","author":"Haase","year":"2021","journal-title":"Kidney Int. Supplements(2011)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12325-020-01524-6","article-title":"Burden of anemia in chronic kidney disease: beyond erythropoietin","volume":"38","author":"Hanna","year":"2021","journal-title":"Adv. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/1753425918780985","article-title":"Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation","volume":"24","author":"He","year":"2018","journal-title":"J. Innate Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.010","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1523-1755.1998.00981.x","article-title":"Immunologic function and survival in hemodialysis patients","volume":"54","author":"Kimmel","year":"1998","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/13510002.2018.1462027","article-title":"Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and treg cells","volume":"23","author":"Lai","year":"2018","journal-title":"Redox Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s10875-012-9742-8","article-title":"Grape seed proanthocyanidin extract attenuates allergic inflammation in murine models of asthma","volume":"32","author":"Lee","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000504850","article-title":"Treatment of renal anemia with roxadustat: advantages and achievement","volume":"6","author":"Li","year":"2020","journal-title":"Kidney Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"788977","DOI":"10.3389\/fphar.2021.788977","article-title":"Roxadustat (FG-4592) facilitates recovery from renal damage by ameliorating mitochondrial dysfunction induced by folic acid","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15638","DOI":"10.18632\/aging.103726","article-title":"Protection of procyanidin B2 on mitochondrial dynamics in sepsis associated acute kidney injury via promoting Nrf2 nuclear translocation","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"806891","DOI":"10.3389\/fphar.2021.806891","article-title":"Tannins as hemostasis modulators","volume":"12","author":"Marci\u0144czyk","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12882-017-0688-1","article-title":"Renal association clinical practice guideline on anaemia of chronic kidney disease","volume":"18","author":"Mikhail","year":"2017","journal-title":"BMC Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI20945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J. Clin. Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000486936","article-title":"Renal anemia and iron metabolism","volume":"195","author":"Ogawa","year":"2018","journal-title":"Contributions Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1523-1755.1998.00032.x","article-title":"C-reactive protein as an outcome predictor for maintenance hemodialysis patients","volume":"54","author":"Owen","year":"1998","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e159235","DOI":"10.1172\/jci.insight.159235","article-title":"Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages","volume":"8","author":"Patino","year":"2023","journal-title":"JCI Insight"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1182\/blood.2019004653","article-title":"A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease","volume":"136","author":"Petzer","year":"2020","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/antiox9080752","article-title":"Chronic kidney disease as oxidative Stress- and inflammatory-mediated cardiovascular disease","volume":"9","author":"Podkowi\u0144ska","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e256738","DOI":"10.1136\/bcr-2023-256738","article-title":"Marked reactive thrombocytosis in a female with iron deficiency anaemia","volume":"16","author":"Sharma","year":"2023","journal-title":"BMJ Case Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: a review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12882-018-0861-1","article-title":"Prevalence, treatment patterns, and healthcare resource utilization in medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States","volume":"19","author":"St Peter","year":"2018","journal-title":"BMC Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1525-139x.2002.00083.x","article-title":"Inflammation in end-stage renal disease: sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Seminars Dialysis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1755.61.s80.19.x","article-title":"Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?","volume":"61","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int. Supplments"},{"key":"B43","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.xinn.2022.100322","article-title":"Herbgenomics: decipher molecular genetics of medicinal plants","volume":"3","author":"Sun","year":"2022","journal-title":"Innov. (Camb)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"11543","DOI":"10.1021\/jf203170k","article-title":"Immunomodulatory and antitumor activities of grape seed proanthocyanidins","volume":"59","author":"Tong","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ncpneph0847","article-title":"Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?","volume":"4","author":"Vaziri","year":"2008","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fphar.2018.00803","article-title":"Correction of anemia in chronic kidney disease with Angelica sinensis polysaccharide via restoring EPO production and improving iron availability","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6651367","DOI":"10.1155\/2021\/6651367","article-title":"Uremic toxins, oxidative stress, atherosclerosis in chronic kidney disease, and kidney transplantation","volume":"2021","author":"Wojtaszek","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/stem.1379","article-title":"Concise review: erythroid versus myeloid lineage commitment: regulating the master regulators","volume":"31","author":"Wolff","year":"2013","journal-title":"Stem Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3858\/emm.2011.43.10.062","article-title":"Grape seed proanthocyanidin extract ameliorates monosodium iodoacetate-induced osteoarthritis","volume":"43","author":"Woo","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e14275","DOI":"10.1111\/acel.14275","article-title":"Macrophage iron dyshomeostasis promotes aging-related renal fibrosis","volume":"17","author":"Wu","year":"2024","journal-title":"Aging Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1182\/blood.2024024293","article-title":"Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis","volume":"144","author":"Xu","year":"2024","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.metop.2020.100049","article-title":"Low dose of sodium-glucose transporter 2 inhibitor ipragliflozin attenuated renal dysfunction and interstitial fibrosis in adenine-induced chronic kidney disease in mice without diabetes","volume":"7","author":"Yamato","year":"2020","journal-title":"Metabol. Open"},{"key":"B53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0272-6386(00)70200-9","article-title":"C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3177\/jnsv.30.245","article-title":"Biochemical features induced by adenine feeding in rats. Polyuria, electrolyte disorders, and 2,8-dihydroxyadenine deposits","volume":"30","author":"Yokozawa","year":"1984","journal-title":"J. Nutr. Sci. Vitaminology (Tokyo)"},{"key":"B55","first-page":"371","article-title":"2,8-Dihydroxyadenine urolithiasis induced by dietary adenine in rats","volume":"27","author":"Yokozawa","year":"1985","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"B56","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.1039\/d1fo03616e","article-title":"Beneficial effects of procyanidin B2 on adriamycin-induced nephrotic syndrome mice: the multi-action mechanism for ameliorating glomerular permselectivity injury","volume":"13","author":"Zhao","year":"2022","journal-title":"Food and Funct."},{"key":"B57","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.26355\/eurrev_202312_34577","article-title":"Roxadustat protects rat renal tubular epithelial cells from hypoxia-induced injury through the TGF-\u03b21\/Smad3 signaling pathway","volume":"27","author":"Zheng","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1678846\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:20:07Z","timestamp":1762924807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1678846\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":56,"alternative-id":["10.3389\/fphar.2025.1678846"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1678846","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"article-number":"1678846"}}